Navigation Links
New Study Shows That Pharmacogenomics Could Benefit Patients, Spur Investment in Innovation
Date:8/3/2009

WASHINGTON, Aug. 3 /PRNewswire-USNewswire/ -- A new study funded by the National Pharmaceutical Council (NPC) shows that pharmacogenomics -- the field of scientific research focused on learning how genetic profiles predict the body's response to medicines - has the potential to lead to higher levels of research and development (R&D) investment and an increased pace of pharmaceutical innovation, offering substantial benefits for patients.

The study, "The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics," was written by Joseph Cook and Graeme Hunter of NERA Economic Consulting and John Vernon of the University of North Carolina at Chapel Hill, and published in the July issue of PharmacoEconomics. According to the study, pharmacogenomics can provide more focused and targeted information to researchers during the R&D process, potentially reducing the number of patients needed for clinical trials as well as the cost and time required to complete the trials. Products could reach the market faster, providing a longer period of time over which the innovator companies could recoup the investment costs of developing products.

"We may see pharmacogenomics pushing us in the right direction of more investment in pharmaceuticals," said study author John Vernon. "The main features likely to drive this phenomenon are the ability of pharmacogenomics to drive adoption of drugs and lower costs of development and time to commercialization. Of course, we have yet to see how these factors are likely to play out, but pharmacogenomics has the makings of a powerful force for economic change and encouraging the financing of new drugs and treatments for patients."

For example, better information about the patients who are more likely to respond to a medication could increase the rate of use of that medicine. Biological markers also could help to ident
'/>"/>

SOURCE National Pharmaceutical Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American ... access to essential pain medications for people living with ... the Pain initiative, this new partnership will help improve ... throughout the country. , Swaziland has the highest ... percent of adults ages 15-49 infected. Many of these ...
(Date:7/29/2014)... Representatives with BNatrl announced today that it ... Silver Solution 12ppm . , “It’s safe for everyday ... LLC. “It helps boost your immune system and protect ... microbes.” , BNatrl develops and manufactures organic food and ... percent of profits being used to fund projects that ...
(Date:7/29/2014)... Nashville, TN (PRWEB) July 29, 2014 ... company specializing in anesthesia, pain management and critical care, ... , “Ryan came to PhyMed in May 2013 as ... become an essential part of our organization and leadership ... officer. “Technological innovation is a cornerstone of our strategic ...
(Date:7/29/2014)... 2014 This Latest Guidebook for Conducting ... (2014 Edition) not only provided a comprehensive and thorough ... for imported drug registration but also introduced the practical ... guide you to use the Chinese trial venues to ... world step by step. , The audiences of this ...
(Date:7/29/2014)... 29, 2014 The report “Cloud ... Software (Database Application Builder, Data Scaling and Replication, ... Paas, Dbaas) and Service Models (Public Cloud, Private ... Size (Small And Medium, Large) - Global Advancements, ... the global cloud database and DBaaS market into ...
Breaking Medicine News(10 mins):Health News:New partnership to improve access to essential pain medications for people living with HIV 2Health News:BNatrl Launches New Silver Solution Product 2Health News:PhyMed Names Dorr to Chief Information Office Post 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Cloud Database and DBaaS Market by Databases Worth $14.05 Billion by 2019 - New Report by MarketsandMarkets 5
... ... today. As competitors come together to expand their reach globally or complete ... of safety programs. , A new free, white paper from Howard Leight ... details how the merger between US Airways and America West led the ...
... , , ALPHARETTA, Ga., Dec. 15 ... the 4th annual event recognized 2009,s best eLearning designs. ... 4 categories. The Venza Group entry, a highly engaging ... as the winner of the "Greater Than 100 Hours of ...
... in brain cancer cells may offer a new option ... are driven by amplified signaling of the epidermal growth ... researchers at UCLA,s Jonsson Comprehensive Cancer Center. Rapidly ... of new membranes. The fatty acids also provide an ...
... Spanish scientists have found the first potential immunological clue ... by the pandemic H1N1 virus. The study ... patients, 15 outpatients and 15 control subjects in 10 ... and August 2009. Researchers from the Hospital Clinico Universitario ...
... ... Agency has requested documents from an investigative journalist, even though the writer had earlier ... ... 2009 -- In a bizarre about-face, the secretive Central Intelligence Agency has requested documents ...
... the virus, expert says , TUESDAY, Dec. 15 (HealthDay News) ... HIV decreased by more than half after the introduction of ... , HIV is the virus that causes AIDS. , Yet ... HIV remained much higher than that of the general population, ...
Cached Medicine News:Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 2Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 3Health News:New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways 4Health News:The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 2Health News:Targeting brain cancer cell metabolism may provide new treatment 2Health News:Targeting brain cancer cell metabolism may provide new treatment 3Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:HIV Therapy Linked to Fewer Suicides 2
(Date:7/29/2014)... July 29, 2014 /PRNewswire-iReach/ -- MHG Medical Management ... launched its Medical Equipment and X-ray Annual ... are tailored to the cruise industry,s unique requirements.  ... operators to propose that they should develop a ... program is intended to create standardized processes and ...
(Date:7/29/2014)... YORK , July 29, 2014 McGraw-Hill ... services for the science, technical, and medical communities, has ... the first off-line mobile application of the world-renowned medical ... the new AccessMedicine App , available for download ... will now be able to gain access to valuable ...
(Date:7/29/2014)... (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at ... Lab Expo today by unveiling two booths (#1209 and ... with customers to redefine the value of the laboratory. ... they,re looking for a partner to help them maximize ... said Jack Phillips , president and CEO of ...
Breaking Medicine Technology:MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... - Amgen,(Nasdaq:AMGN) today presented the results from a ... safety of Aranesp(R) (darbepoetin alfa) for the,treatment of ... or radiotherapy ("the 103 study"). Aranesp is not,approved ... these patients. These,results were presented in an oral ...
... therapeutic approach for the treatment,of early and metastatic ... - AEterna,Zentaris Inc. , a global, pure play ... presented an,abstract outlining in vivo data for its ... at the American,Association for Cancer Research (AACR) Annual ...
Cached Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
... two centrifuges -- the world's most popular ... in one reliable, quiet, compact unit. It ... two separate centrifuges!, For your microcentrifuge needs, ... supplies you with the MicroMB centrifuge, microcentrifuge ...
... Centrifuge 4-15C is designed to accommodate the deep-well ... necessary force of more than 5600 x g ... of both fixed-angle and swing-out rotors are available ... 15 ml, and 50 ml tubes, as well ...
... Model 5415D is an ideal workhorse for the ... of time and speed/g-force. , Product features ... , Compact 9 x 12-inch (W x D) ... a cold room , 24-place capacity ...
Medicine Products: